Genmab buys PDL Biopharma antibody plant for $240M

02/21/2008 | American City Business Journals

California-based PDL Biopharma completed the $240 million sale of its antibody manufacturing plant in Minnesota to Danish company Genmab A/S in a move to reduce its assets. The deal, which includes access to a leased development lab and other equipment, allows Genmab to supply clinical quantities of antibodies for PDL studies and retain the plant's 170 workers.

View Full Article in:

American City Business Journals

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Assistant General Counsel/Senior Corporate Counsel
Genentech
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD